Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2011
01/06/2011WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors
01/06/2011WO2009116081A3 An improved process for the preparation of aprepitant
01/06/2011US20110003994 Cycloalkane derivative
01/06/2011US20110003988 3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) -6- (pyrim-idin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor
01/06/2011US20110003985 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same
01/06/2011US20110003831 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent
01/06/2011US20110003825 Substituted amide beta secretase inhibitors
01/06/2011US20110003822 P2x3 receptor antagonists for treatment of pain
01/06/2011US20110003818 Substituted 2-Carboxamide Cycloamino Ureas
01/06/2011US20110003817 Whitening Agent And Skin External Preparation
01/06/2011US20110003815 Diphenyl substituted cycloalkanes
01/06/2011US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels
01/06/2011US20110003813 Substituted biaryl piperazinyl-pyridine analogues
01/06/2011US20110003812 Human Adam-10 Inhibitors
01/06/2011US20110003809 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
01/06/2011US20110003808 Octahydroquinolizines for antidiabetic treatment
01/06/2011US20110003807 Thiazole derivatives
01/06/2011US20110003806 Heteroaryls and uses thereof
01/06/2011US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
01/06/2011US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
01/06/2011US20110003794 Naphthyridine Integrase Inhibitors
01/06/2011US20110003789 5-aminocyclylmethyl-oxazolidin-2-one derivatives
01/06/2011US20110003787 Novel phenylpyrrole derivative
01/06/2011US20110003785 Fused Thiazole Derivatives As Kinase Inhibitors
01/06/2011US20110003780 Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof
01/06/2011US20110003316 Luminescence-based methods and probes for measuring cytochrome p450 activity
01/06/2011US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues
01/06/2011CA2767064A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
01/05/2011EP2270113A1 Ultraviolet absorbent compositions
01/05/2011EP2270076A1 Resin molded product and polymer film
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2269996A1 Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease
01/05/2011EP2269993A1 2-aminoquinazoline derivative
01/05/2011EP2269985A2 Substituted tetracycline compounds
01/05/2011EP2268615A1 Pesticides
01/05/2011EP2268311A1 Non-invasive systems and methods for in-situ photobiomodulation
01/05/2011EP1824489B1 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
01/05/2011EP1661890B1 Ppar-activating compound and pharmaceutical composition containing same
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011CN101939318A Substituted piperidines as renin inhibitors
01/05/2011CN101939317A Substituted aryloxazoles and the use thereof
01/05/2011CN101939311A Heterocyclic compounds with affinity to muscarinic receptors
01/05/2011CN101939055A 2-aminoquinolines
01/05/2011CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
01/05/2011CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
01/05/2011CN101439191B Synthesizing method of visible light induced zinc ion fluorescence angiographic reagent capable of being applied in cell/tissue/living body
01/05/2011CN101143854B Synthesis method for dibenzoxazole compounds
01/04/2011US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
01/04/2011US7863314 Pyrazole and/or imidazole based compounds; inflammatory diseases and disorders; synthesis
01/04/2011US7863310 Kinase inhibitors
01/04/2011US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
01/04/2011US7863299 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine D3 receptor modulators
01/04/2011US7863293 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
01/04/2011US7863286 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity
01/04/2011US7863282 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles
01/04/2011US7863277 antipsychotic (ziprasidone and quetiapine) encapsulated in cyclodextrin, and a dermatologically acceptable carrier consisting of ethoxy diglycol, lecithin soya, isopropyl palmitate, poloxamer and water; schizophrenia; Bipolar disorders
01/04/2011US7863271 2-aminobenzoxazole carboxamides as 5HT3 modulators
01/04/2011US7863266 Therapeutic pyrazoloquinoline urea derivatives
01/04/2011US7863265 N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[(2R or S)-2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl-D-lysine, used as anticholesterol agents
01/04/2011CA2465207C Pyrazole-amides and -sulfonamides
01/04/2011CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
01/04/2011CA2454703C Novel thiophene carboxamide derivatives
01/04/2011CA2451238C Cyclic diamine compound with 5 membered ring groups
01/04/2011CA2427750C Substituted alkanoic acids
01/04/2011CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
01/04/2011CA2375008C Phenoxypropylamine compounds
12/2010
12/30/2010US20100331551 Alpha-haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
12/30/2010US20100331372 Pyridin-2-yl derivatives as immunomodulating agents
12/30/2010US20100331369 Therapeutic Agents Useful for Treating Pain
12/30/2010US20100331346 Beta-amino acid derivatives for treatment of diabetes
12/30/2010US20100331342 Immuno Inhibitory Pyrazolone Compounds
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331328 Bicyclylaryl-aryl-amine compounds and their use
12/30/2010US20100331327 7-substituted indirubin-3'oximes and their applications
12/30/2010US20100331326 Inhibitors of CYP 17
12/30/2010US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
12/30/2010US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
12/30/2010US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/30/2010US20100331322 Substituted piperidines as renin inhibitors
12/30/2010US20100331320 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/30/2010US20100331318 Azatricyclic antibiotic compounds
12/30/2010US20100331317 Benzodiazepine compound and pharmaceutical composition
12/30/2010US20100331308 Oxazolidinone derivatives
12/30/2010US20100331306 Heterocyclic compounds and their uses
12/30/2010US20100331304 Compounds Which Modulate The CB2 Receptor
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331301 Azetidine compound and pharmaceutical use thereof
12/30/2010US20100331298 Carboxamide Compounds and Their Use
12/30/2010US20100331295 Modulators of lxr
12/30/2010US20100331293 Heterocyclic compounds and their uses
12/30/2010US20100331282 Pyridine derivative containing ((phosphonooxy)methyl)pyridinium ring, and antifungal agent containing these derivative
12/30/2010US20100330584 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329978 Highly selective sigma receptor ligands
12/29/2010WO2010151791A1 Heterocyclic compounds and their uses
12/29/2010WO2010151160A1 O-substituted 3-n-heteroaryl-1,3,4-oxadiazolones for medical use
12/29/2010WO2010150840A1 N-substituted-cyclic amino derivative
12/29/2010WO2010150281A2 Novel azabicyclohexanes
12/29/2010WO2010149684A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010149622A1 Ambipolar small molecule hosts for phosphorescent guest emitters